Covid tests will remain reimbursed without prescription for vaccinated adults and minors, announces Jean Castex

  • By kjhg

“It is no longer legitimate to overpay for comfort tests at taxpayer expense.” Jean Castex confirmed on Sunday September 26 the end of free “comfort” screening tests for Covid-19 on October 15, while specifying that they will continue to be reimbursed for medical reasons, without requiring a prescription for people vaccinated, in an interview with Échos .

Read alsoCovid-19: the weekly number of tests falls below the four million mark

“But tests will continue to be reimbursed for medical reasons, either without a prescription for people who have already been vaccinated, or on prescription for others. We also want to maintain free access for minors,” he adds.

Encourage to get vaccinated

“The logic is to reimburse tests linked to truly medical reasons, and to continue to encourage people to be vaccinated”, insists the Prime Minister. During his speech on July 12, Emmanuel Macron announced that the “comfort” tests would become chargeable in the fall.

Read alsoTravel to Morocco: suspension of flights, vaccines, tests... What you need to know

The measure is supposed to encourage vaccination, while the number of first doses injected daily tends to drop. As of September 23, according to data from the Ministry of Health, 74.7% of French people have received at least one dose of vaccine, and 71.6% have received a complete vaccination schedule. If vaccination is at this stage reserved for French people over the age of twelve, there are still audiences to conquer among the adult populations. Thus, 10% of those over 75 received no dose, a rate which reaches 15% among 30-49 year olds and 29% among 12-17 year olds, for whom vaccination was opened on June 15.

As an incentive for vaccination, the reimbursement of tests also aims to reduce the bill for screening, which cost 2.2 billion euros in 2020 and for which 4.9 billion are planned this year.

SEE ALSO - Do vaccines promote the appearance of new variants?

  • Tags: